HHS’ Secretary Mike Leavitt’s entry in his professional blog Thursday — which denied that draft HHS regulations would redefine several common contraceptives as abortion and allow health care workers to refuse to provide them — did not ease concerns among some members of Congress and advocates, the
More: continued here
Filed under: Abortion on August 12th, 2008 | Comments Off
Anthony Shannon made history on July 30. That’s when he became the first person in the United States to receive a new type of experimental and very high-tech heart-assist device. Called a DuraHeart, it was implanted in his chest, and connected to his failing heart, to help […]
Filed under: Cardiovascular on August 11th, 2008 | Comments Off
A new drug in a new class provides another option for improving blood glucose control in diabetes, but its effect on diabetes-related complications and mortality is not known. NPS RADAR reminds prescribers that when it comes to weighing up treatment options for people with diabetes, some drugs do have evidence for preventing diabetes-related complications as […]
Filed under: Diabetes on August 11th, 2008 | Comments Off
An international team of researchers has identified just 200 positions within the curves of the DNA helix that they believe capture much of the genetic diversity in European Americans, a population with one of the most diverse and complex historic origins on Earth. Their findings narrow the search for the elusive ancestral clues known […]
Filed under: Genetics on August 11th, 2008 | Comments Off
Scientists have made great strides in understanding how the thymus functions, including the timing, regulation, and mechanism of the process of negative selection, according to an article released on August 4, 2008 in the open-access journal PLoS Biology. The immune system has a highly evolved […]
Filed under: Biology on August 11th, 2008 | Comments Off
Inhibitex, Inc. (NASDAQ: INHX), a biopharmaceutical company focused on the development of products to treat serious infectious diseases, announced today that it has completed a Phase I single ascending dose (SAD) clinical trial and initiated a multiple ascending dose (MAD) trial of FV-100, a highly potent and fast-acting compound being developed to treat shingles (herpes […]
Filed under: Clinical Trials on August 11th, 2008 | Comments Off
As the weather gets warmer, people often get motivated to spend more time outdoors. Whether it’s working on projects around the house, playing with the grandkids at the park or out exercising, it’s important that baby boomers remember their bodies are not as young as they used to be and not overdo it.
More: continued […]
Filed under: Bones on August 11th, 2008 | Comments Off
The New York Times on Thursday examined “concern” among some Democrats that Democratic presidential candidate Sen. Barack Obama (Ill.), who supports abortion rights, needs “to do more to regain the allegiance of Roman Catholic voters.” In the Democratic primary earlier this year, Sen. Hillary Rodham Clinton (N.Y.
More: continued here
Filed under: Abortion on August 11th, 2008 | Comments Off
Genzyme Corp. (Nasdaq: GENZ) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced that they have begun a phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH), a genetic disorder that causes exceptionally high levels of LDL cholesterol. It is the first of four new trials the companies […]
Filed under: Cholesterol on August 11th, 2008 | Comments Off
Private-sector employers and their employees have seen their health insurance premium costs go up by more than 100 percent since 1996, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
More: continued here
Filed under: Health Insurance / Medical Insurance on August 11th, 2008 | Comments Off